AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Regen BioPharma, Inc.

$0 -$0.01 (-97.72%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.04
Market Cap
6.31K
AVG Volume
26.7M
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
020K40K60K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q359.06K
26 Q259.06K
26 Q159.06K
25 Q459.37K
25 Q359.06K
25 Q259.06K
25 Q159.06K
24 Q459.37K
24 Q359.06K
24 Q259.06K
Net Income (USD)
-1M-500K0500K1M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q3-637.78K
26 Q2991.93K
26 Q1-967.85K
25 Q4-572.47K
25 Q3-167.29K
25 Q2-19.35K
25 Q1-515K
24 Q4-264.9K
24 Q3-117.11K
24 Q2-122.47K
Operating Income (USD)
-600K-400K-200K0200K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q324.53K
26 Q2-153.71K
26 Q1-551.62K
25 Q4-123.06K
25 Q3-40.76K
25 Q2-113.35K
25 Q1-61.38K
24 Q4-84.96K
24 Q3-107.97K
24 Q2-101.07K
EBITDA (USD)
-600K-400K-200K0200K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q324.53K
26 Q2-145.05K
26 Q1-542.77K
25 Q4-472.27K
25 Q3-130.01K
25 Q215.61K
25 Q1-423K
24 Q4-326.3K
24 Q3-108.23K
24 Q2-101.07K
Cash Flows (USD)
-300K-200K-100K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q3-24.07K
26 Q2-63.23K
26 Q1-197.94K
25 Q4-160K
25 Q3-55.98K
25 Q2-101.23K
25 Q1-66.38K
24 Q4-148.9K
24 Q3-172.59K
24 Q2-209.32K
EPS (USD)
-0.08-0.06-0.04-0.0200.0224 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP EPS (USD) by quarter
PeriodEPS (USD)
26 Q3-0
26 Q20.01
26 Q1-0.01
25 Q4-0.01
25 Q3-0.01
25 Q2-0
25 Q1-0.07
24 Q4-0.06
24 Q3-0.03
24 Q2-0.03
Expenses (USD)
-200K0200K400K600KR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q334.54K
26 Q2212.77K
26 Q1595.69K
25 Q4182.42K
25 Q399.82K
25 Q2172.41K
25 Q1120.44K
24 Q4145.74K
24 Q3167.03K
24 Q2160.13K
Cash & Debt (USD)
0500K1M1.5MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q3239
26 Q2271
26 Q14.58K
25 Q469.56K
25 Q31.76K
25 Q21.76K
25 Q1135
24 Q4716
24 Q361.85K
24 Q278.11K
Debt ratios
-1.5-1-0.5024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Debt ratios by quarter
PeriodDebt ratios
26 Q3-0.81
26 Q2-0.74
26 Q1-1.07
25 Q4-1.12
25 Q3-1.2
25 Q2-1.15
25 Q1-0.91
24 Q4-1.1
24 Q3-0.91
24 Q2-0.91
Margins
0%25%50%75%100%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Margins by quarter
PeriodMargins
26 Q3100%
26 Q2100%
26 Q1100%
25 Q4100%
25 Q3100%
25 Q2100%
25 Q1100%
24 Q4100%
24 Q3100%
24 Q270.85%
Return on Capital
-20%-10%0%10%20%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Return on Capital by quarter
PeriodReturn on Capital
26 Q310.85%
26 Q2-18.51%
26 Q114.72%
25 Q49.11%
25 Q32.88%
25 Q20.34%
25 Q19.19%
24 Q45.1%
24 Q32.27%
24 Q22.37%
Shares Outstanding
0200M400M600M800M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Shares Outstanding by quarter
PeriodShares Outstanding
26 Q3615.56M
26 Q2184.94M
26 Q199.61M
25 Q439.37M
25 Q323.75M
25 Q221.55M
25 Q18.22M
24 Q44.11M
24 Q34.21M
24 Q23.94M
Book Value Per Share (USD)
-1.5-1-0.5024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q3-0.01
26 Q2-0.03
26 Q1-0.07
25 Q4-0.16
25 Q3-0.24
25 Q2-0.26
25 Q1-0.68
24 Q4-1.26
24 Q3-1.22
24 Q2-1.31
Total Assets (USD)
0100K200K300K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
RGBP Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q3287.59K
26 Q2260.19K
26 Q1237.08K
25 Q4274.63K
25 Q3196.84K
25 Q2169.48K
25 Q1196.78K
24 Q4177.61K
24 Q3170.15K
24 Q2140.77K
Employee Count
01234201420152016201720182022202320242025
RGBP Employee Count by quarter
PeriodEmployee Count
20251
20241
20231
20221
20184
20174
20164
20154
20143
PE Ratio
050100150200med 1.91May 23Jun 23Jul 23Sep 23Oct 23Dec 23Jan 24
RGBP PE Ratio by quarter
PeriodPE Ratio
Jan 241.28
Jan 241.23
Dec 231.64
Dec 231.29
Dec 231.42
Dec 231.95
Dec 232.14
Nov 232.32
Nov 231.8
Nov 231.92
Nov 231.94
Oct 232.23
Oct 232.18
Oct 232.17
Oct 232.24
Sep 232.24
Sep 232.11
Sep 232.18
Sep 232.41
Sep 232.04
Aug 231.98
Aug 232.14
Aug 232.45
Aug 232.04
Jul 231.91
Jul 230.05
Jul 230.05
Jul 230.05
Jun 230.05
Jun 230.05
Jun 230.05
Jun 230.05
Jun 230.05
May 230.05
May 230.06
May 230.06
May 230.04
Apr 230.05
Apr 230.06
Aug 21192.7
Aug 219.9
Aug 2110.41
Free Cash Flow Yield
-80000%-60000%-40000%-20000%0%med -178.27%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RGBP Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-361.67%
Sep 26-723.34%
Aug 26-72333.67%
Aug 26-723.34%
Aug 26-2580.02%
Aug 26-1720.01%
Jul 26-1290.01%
Jul 26-1720.01%
Jul 26-2580.02%
Jul 26-1720.01%
Jul 26-2580.02%
Jun 26-1290.01%
Jun 26-1290.01%
Jun 26-1290.01%
Jun 26-860.01%
May 26-860.01%
May 26-737.15%
May 26-645%
May 26-1034.34%
May 26-1477.63%
Apr 26-1034.34%
Apr 26-861.95%
Apr 26-861.95%
Apr 26-861.95%
Mar 26-861.95%
Mar 26-861.95%
Mar 26-646.46%
Mar 26-615.68%
Feb 26-487.9%
Feb 26-470.16%
Feb 26-369.41%
Feb 26-274.43%
Jan 26-170.61%
Jan 26-101.48%
Jan 26-162.37%
Jan 26-170.91%
Jan 26-111.15%
Dec 25-165.07%
Dec 25-156.82%
Dec 25-220.87%
Dec 25-163.35%
Nov 25-142.56%
Nov 25-172.33%
Nov 25-156.82%
Nov 25-130.68%
Oct 25-120.96%
Oct 25-112.01%
Oct 25-120.63%
Oct 25-78.41%
Oct 25-92.25%
Sep 25-125.46%
Sep 25-120.63%
Sep 25-78.8%
Sep 25-72.94%
Aug 25-80.42%
Aug 25-60.32%
Aug 25-40.84%
Aug 25-56.73%
Aug 25-41.38%
Jul 25-28.36%
Jul 25-25.5%
Jul 25-52.65%
Jul 25-45.38%
Jun 25-38.46%
Jun 25-49.33%
Jun 25-41.11%
Jun 25-52.28%
May 25-32.42%
May 25-142.16%
May 25-145.28%
May 25-201.22%
May 25-215.55%
Apr 25-249.48%
Apr 25-224.91%
Apr 25-237.18%
Apr 25-221.03%
Mar 25-269.44%
Mar 25-192.46%
Mar 25-244.94%
Mar 25-186.59%
Feb 25-191.09%
Feb 25-204.12%
Feb 25-189.74%
Feb 25-166.83%
Jan 25-176.1%
Jan 25-176.91%
Jan 25-191.36%
Jan 25-134.72%
Jan 25-150.52%
Dec 24-192.46%
Dec 24-179.62%
Dec 24-134.72%
Dec 24-125.69%
Nov 24-244.5%
Nov 24-158.49%
Nov 24-175.41%
Nov 24-134.72%
Nov 24-116.64%
Oct 24-84.2%
Oct 24-55.11%
Price to Sales
02.557.510med 1.14Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RGBP Price to Sales by quarter
PeriodPrice to Sales
Sep 260.52
Sep 260.26
Aug 260
Aug 260.26
Aug 260.08
Aug 260.12
Jul 260.16
Jul 260.12
Jul 260.08
Jul 260.12
Jul 260.08
Jun 260.16
Jun 260.16
Jun 260.16
Jun 260.23
May 260.23
May 260.27
May 260.31
May 260.21
May 260.15
Apr 260.21
Apr 260.25
Apr 260.25
Apr 260.25
Mar 260.25
Mar 260.25
Mar 260.34
Mar 260.35
Feb 260.45
Feb 260.46
Feb 260.59
Feb 260.59
Jan 260.95
Jan 261.6
Jan 261
Jan 260.95
Jan 261.46
Dec 250.95
Dec 251
Dec 250.71
Dec 250.96
Nov 251.1
Nov 250.91
Nov 251
Nov 251.2
Oct 251.3
Oct 251.41
Oct 251.31
Oct 252.01
Oct 251.71
Sep 251.26
Sep 251.31
Sep 252
Sep 252.16
Aug 251.96
Aug 252.61
Aug 253.86
Aug 253.64
Aug 255
Jul 257.29
Jul 258.11
Jul 253.93
Jul 254.56
Jun 255.38
Jun 254.19
Jun 255.03
Jun 253.95
May 256.38
May 251.78
May 251.74
May 251.19
May 251.11
Apr 250.96
Apr 251.07
Apr 251.01
Apr 251.09
Mar 250.89
Mar 251.25
Mar 250.98
Mar 251.29
Feb 251.26
Feb 251.18
Feb 251.26
Feb 251.44
Jan 251.36
Jan 251.36
Jan 251.25
Jan 251.78
Jan 251.59
Dec 241.25
Dec 241.34
Dec 241.78
Dec 241.91
Nov 240.98
Nov 241.51
Nov 241.37
Nov 241.78
Nov 242.06
Oct 242.85
Oct 244.35
EV/EBITDA
010203040med 1.73Aug 19Aug 22Nov 22Mar 23Jun 23Sep 23Jan 24
RGBP EV/EBITDA by quarter
PeriodEV/EBITDA
Jan 241.11
Jan 241.08
Dec 231.32
Dec 231.12
Dec 231.19
Dec 231.5
Dec 231.61
Nov 231.71
Nov 231.56
Nov 231.65
Nov 231.66
Oct 231.86
Oct 231.83
Oct 231.82
Oct 231.87
Sep 231.87
Sep 231.78
Sep 231.83
Sep 231.99
Sep 231.73
Aug 231.69
Aug 231.8
Aug 232.02
Aug 231.73
Jul 231.64
Jul 230.05
Jul 230.05
Jul 230.05
Jun 230.05
Jun 230.05
Jun 230.05
Jun 230.05
Jun 230.06
May 230.06
May 230.07
May 230.06
May 230.04
Apr 230.05
Apr 230.06
Apr 231.75
Apr 231.69
Mar 231.73
Mar 231.76
Mar 232.09
Mar 231.71
Mar 232.43
Feb 231.97
Feb 232.54
Feb 232.54
Feb 235.23
Jan 235.63
Jan 235.69
Jan 234.1
Jan 233.48
Dec 223.46
Dec 223.61
Dec 223.69
Dec 223.91
Dec 223.83
Nov 224.31
Nov 224.41
Nov 2216.51
Nov 2218.22
Oct 2217.33
Oct 2217.62
Oct 2217.85
Oct 2219.41
Sep 2219.85
Sep 2220.97
Sep 2222.08
Sep 2220.67
Sep 2223.5
Aug 2227.36
Aug 2230.48
Aug 2231
Aug 2232.27
Jul 2218.44
Jul 2217.4
Aug 2125.86
Aug 215.07
Aug 214.8
Oct 191.02
Oct 191.01
Oct 191.03
Sep 191.03
Sep 191.03
Sep 191.03
Sep 191.03
Aug 191.02
Aug 191.49
Aug 191.52
Aug 191.58
Aug 191.45
Jul 191.46
Jul 191.44
Jul 191.47
Jul 191.47
Jun 191.47
Jun 191.48
Jun 191.46
Price/Operating Cashflow
0500100015002000med 409.02Aug 21Aug 21Aug 21
RGBP Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 211582.51
Aug 21409.02
Aug 2130.9
Regen BioPharma, Inc.
RGBP
Stockpicker

Video analysis: RGBP

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.